Study: Human blood antibody relieves chronic pain condition

02/1/2010 | National Post (Canada)

U.K. scientists found that almost half of 13 patients with complex regional pain syndrome experienced pain relief for an average of five weeks after receiving a low-dose transfusion of intravenous immunoglobulin, a human blood antibody. "The discovery is expected to have a real impact on the treatment of other unexplained chronic pain conditions," the lead researcher said.

View Full Article in:

National Post (Canada)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID